Drug Combination Details
General Information of the Combination (ID: C34676) | |||||
---|---|---|---|---|---|
Name | Alpha linolenic acid NP Info | + | Cisplatin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Healthy individual
[ICD-11: N.A.]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Decreasing Adverse Drug Reaction by This Combination | ||||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | COX-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | NOS2 | Molecule Info |
Pathway MAP
|
||
In-vivo Model | Male BALB/c albino mice weighing 30 g were used in this study. | |||||
Experimental
Result(s) |
ALA, an n-3 fatty acid, has a protective effect in mice renal tissue. |
References | ||||
---|---|---|---|---|
Reference 1 | Alpha-linolenic acid confers protection on mice renal cells against cisplatin-induced nephrotoxicity. Cytotechnology. 2019 Oct;71(5):905-914. |




